Unibest

Pharmaceutical intermediates

Aripiprazole Intermediates

2 pharmaceutical intermediates for Aripiprazole. Indication: Autism spectrum disorder; Mania; Severe depression; Schizophrenia; Tourette's disorder.

Submit a ProjectAll intermediates

About Aripiprazole

Originator
Otsuka Pharmaceutical Co Ltd
Indication
Autism spectrum disorder; Mania; Severe depression; Schizophrenia; Tourette's disorder
Approved Date
11/15/2002
DS/DP
07/28/2026

Available intermediates

2 intermediates currently listed for Aripiprazole. Request specifications, documentation or a quotation for any item below.

Aripiprazole intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
3,4-Dihydro-7-(4-bromobutoxy)-2(1H)-quinolinone129722-34-5//
1-(2,3-Dichlorophenyl)piperazine hydrochloride119532-26-2//

Other programs under A

AbemaciclibAbrocitinibAcalabrutinibAdagrasibAfatinibAfoxolanerAlectinib HydrochlorideAlfacalcidol

Building toward Aripiprazole?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

Submit a Project Talk to the team

How can we help you?

Receive insights into the latest events and regulatory updates

Sent directly to your email

Get industry insights and Unibest news here

Contact Us →